Kiss them. They’re Irish. ☘️ 🌈

Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy - OncoDaily Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy / Amy C. Moore, cancer, ivonescimab, Lung cancer, OncoDaily,

Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy
@acmoorephd.bsky.social

oncodaily.com/blog/255749

#Cancer #Medicine #PatientAdvocacy #Health #HealthCare #Oncology #OncoDaily

Digging around in the basement and found this old award from AACR broken. But I glued it back together. Because science may be down right now, but it’s not out. We will put the pieces back together.

Here is the pre-RFK vaccination schedule for your kids. Please download it before he is confirmed and changes/deletes it.

Give it to your pediatrician and say this is the schedule you want your kids on.

Making this my pinned post.

I am proud to have worked with LUNGevity’s partners to develop these #lungcancer resources for members of the AANHPI community lungevity.org/health-equity #LCSM

As February begins, we embrace a month dedicated to recognizing the extraordinary achievements of Black individuals who have shaped our world. Their stories inspire us to rise, challenge the status quo, and create a future filled with hope and progress.

I’m an NSF panel reviewer that was scheduled to meet today. Just got notice that all NSF panels were canceled today. I reviewed some innovative proposals in support of students. Devastating if these scholars don’t get to do this work. For the love of science & students I hope this is just a delay.💔

Four tips for writing the perfect ‘cold e-mail’ in job applications These strategies can transform your unsolicited applications from forgettable to fabulous.

Having landed my first job outside my postdoc through a cold email, I know the power of that communication and how it can open doors www.nature.com/articles/d41...

As a scientist and an advocate, I am grateful for LUNGevity's commitment to continue to work on behalf of ALL people at risk for and impacted by #lungcancer as well as the researchers working to find new treatments. #LCSM

More than 40% of postdocs leave academia, study reveals Publishing highly cited papers helps postdoctoral researchers to land a faculty job.

This will not get better

www.nature.com/articles/d41...

Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews? Have you been affected by the Trump administration’s pause on communications, science meetings, and reviews? @statnews would like to hear from you.

www.statnews.com/2025/01/25/t...

a cat is sitting on a ping pong table looking at a blue balloon . ALT: a cat is sitting on a ping pong table looking at a blue balloon .

The good news is my ping pong game has really improved this week. Burning off some steam!

As a cancer patient community, we are lost for words. Science and research is what keeps us all going.

As Dr @choo.bsky.social said, “There are real people, real lives waiting on the science.”

nature.com/articles/d4158…

#LCSM

A good distraction from a cat-astrophic week for science

FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.

Efforts to support clinical trial diversity now at risk www.statnews.com/2025/01/23/f...

Concurrent PIK3CA mutant drives cachexia through inflammatory signaling in EGFR mutant lung cancer PIK3CA mutation is frequently concurrent with known oncogenic drivers such as EGFR mutation in lung cancer, raising an interesting question about its real function. Cachexia is a systemic disease invo...

One of my frustrations with our work to understand the causes of #cancer #cachexia as part of Cancer Grand Challenges Team #CANCAN is the limitation of animal models that don't reflect the realities of the patient population. This development helps. #LCSM #lungcancer

www.biorxiv.org/content/10.1...

On this day 13 years ago, I was speaking at the Georgia Capitol about the importance of #cancer #research.

Despite what happened yesterday, we continue our work on behalf of those around the world at risk for, living with or impacted by #cancer.

Trump administration’s abrupt cancellation of scientific meetings prompts confusion, concern A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the

"Any prolonged pause of the #NIH’s study sections could result in funding delays for scientific labs awaiting approval of their work." #CanSky #MedSky #IDSky

www.statnews.com/2025/01/22/t...

Trump officials ask US health agencies to pause external communications, Washington Post reports The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites and social media posts, the Washington Post reported on Tuesday, citing a dozen current and former officials and sources.

www.reuters.com/world/us/tru...

First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC The European Commission approved first-line amivantamab plus lazertinib for EGFR-mutated advanced non–small cell lung cancer.

First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC #lcsm #oncology www.onclive.com/view/first-l...

I am so sorry.

My cat may be slightly spoiled

9.5% MET and 7.9% EGFR detected in pts w lung SqCC with no smoking history.

Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease.

#lcsm

We still have a long way to go to ensure that ALL patients benefit from recent scientific advances in #lungcancer. This study found that overall survival increased by 71% in patients with private insurance compared to only 24% in the uninsured in the US. #LCSM

www.jtocrr.org/article/S266...

Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking Next-generation sequencing (NGS) to detect actionable genomic driver alterations (AGAs) is critical to appropriate management of non-small cell lung c…

Biomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM #lungcancer

www.sciencedirect.com/science/arti...

Excellent review of lung neuroendocrine neoplasms by Dr Sen,
@naglaakarimmd.bsky.social and team! Terrific discussion of molecular landscape, existing therapeutic challenges, and diagnosis & management strategies.
#LCSM #LungNETs #SCLC
@thelancet.bsky.social

www.thelancet.com/journals/lan...

Congratulations! I am honored to be a mentor for my 4th year and looking forward to meeting all of this year's mentees!

THIS!

Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer.

Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏
#LCSM #SuppOnc
bit.ly/4jiKwUz

Helping Health Professionals Reduce Lung Cancer Stigma Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.

Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer

Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si

#LCSM #EndStigmaNow

LUNGevity's RFA Day was Jan 13. Our newest mechanism is my baby. We are excited to offer bridge funding to mid-career investigators working in the #lungcancer space. We support workforce development AND retention to ensure a continuous pipeline of leaders to transform the field and improve outcomes.